Disparities by sex in P2Y 12 inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable men following acute myocardial infarction? A P2Y 12 inhibitor new user retrospective cohort analysis of US Medicare claims data
Ryan P. Hickson, Anna M. Kucharska-Newton, Jo E. Rodgers, Betsy L. Sleath, Gang Fang
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Disparities by sex in P2Y 12 inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable men following acute myocardial infarction? A P2Y 12 inhibitor new user retrospective cohort analysis of US Medicare claims data'. Together they form a unique fingerprint.